. 2020 Feb 26;598(6):1187–1203. doi: 10.1113/JP278975

Table 2.

Morphometric characteristics of EDL

	Control	Chronic MS	OV+MS	OV
EDL mass (mg per g M _b)	0.57 ± 0.05^a	0.59 ± 0.06^a	0.68 ± 0.06^b	0.67 ± 0.03^b
Bilateral EDL mass hypertrophy	1.02 ± 0.09^a	1.06 ± 0.010^a	1.19 ± 0.07^b	1.19 ± 0.06^b
Anatomical capillary density (mm²)	617 ± 61^a	556 ± 63^a	813 ± 114^b	836 ± 131^b
Perfused capillary density (mm²)	564 ± 107^a	420 ± 95^b	512 ± 48^ab	728 ± 165^c
Anatomical capillary: muscle fibre	1.47 ± 0.30^ab	1.29 ± 0.13^a	1.66 ± 0.19^b	1.63 ±0.22^b
Perfused capillary: muscle fibre	1.25 ± 0.29^ab	0.96 ± 0.19^a	0.92 ± 0.18^a	1.42 ± 0.31^b
Anatomical CDA (µm²)	1399 ± 156^a	1841 ± 204^b	1414 ± 158^a	1337 ± 155^a
Perfused CDA (µm²)	1854 ± 397^a	2506 ± 765^a	2274 ± 519^a	1759 ± 521^a
Anatomical log_rSD	0.107 ± 0.008^a	0.096 ± 0.010^a	0.100 ± 0.012^a	0.104 ± 0.008^a
Perfused log_rSD	0.127 ±0.016^a	0.109 ± 0.008^a	0.112 ± 0.019^a	0.112 ± 0.014^a
Type I (%)	3.8 ± 2.1^a	3.9 ± 2.2^a	3.3 ± 1.8^a	3.5 ± 2.4^a
Type 1 FCSA (µm²)	922 ± 217^a	1008 ± 138^a	1042 ± 180^a	1010 ± 173^a
Type IIa (%)	21.4 ± 5.0^a	19.9 ± 5.4^a	21.5 ± 4.2^a	23.2 ± 6.2^a
Type IIa FCSA (µm²)	933 ± 99^a	1012 ± 133^ab	1169 ± 120^b	1113 ± 120^b
Type IIb/IIx (%)	74.8 ± 6.9^a	76.2 ± 7.3^a	75.1 ± 4.2^a	73.3 ± 8.5^a
Type IIb/IIx FCSA (µm²)	1644 ± 189^a	2085 ± 310^b	2269 ± 182^b	2121 ± 223^b

Abbreviations: CDA, capillary domain area; FCSA, fibre cross‐sectional area. Superscript letters denote statistical significance (P ≤ 0.05) as assessed by Tukey post hoc tests.